David Boyer

ALG-1001: Turning off the machinery of angiogenesisALG-1001 (Luminate, Allegro Ophthalmics) has a number of different mechanisms of action that benefit patients chronically treated with anti-vascular endothelial growth factor drugs and those who are treatment naïve.
Navilas laser chosen for DME studyOD-OS has announced that its Navilas laser has been selected for a new study to evaluate the efficacy and stability of laser plus anti-vascular endothelial growth factor for the treatment of patients with diabetic macular edema (DME).
Phase II study begins for Allegro VMT treatmentAllegro Ophthalmics LLC has announced the start of a phase II study of ALG-1001 in patients with vitreomacular traction (VMT).